Results

Total Results: 2,463 records

Showing results for "testing".

241. No Slide Title (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_vulnerable_populations_kreps.ppt
     September 05, 2006 - patterns The best message strategies for diverse populations Adapting messages to audiences Message testing

242. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea_research-protocol.pdf
     March 15, 2010 - Preoperative testing People with sleep apnea are at increased risk of surgical and anesthesia-related … KQ3: How does phased testing (screening tests or battery followed by full test) compare to full testing … Key question 3 evaluates phased testing. We will not otherwise review the order of testing. … to receive general anesthesia KQ 5-7 • Diagnosed with obstructive sleep apnea (OSA) o Formal testing … For program testing and training purposes, we will manually screen 1000 abstracts, each twice.

243. Troponin Cardiac Marker Interpretation During Renal Function Impairment | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/renal-function/research-protocol
     June 13, 2013 - Previous reviews and meta-analyses have investigated the prognostic performance of troponin testing in … as part of standard care that “no testing” is not a realistic comparator. … In KQ 4, one comparator of interest would be “no testing” beyond the use of a standard risk-predictor … For the population with suspected ACS (KQs 1–3), biomarker testing is done so routinely as part of a … standard workup that “no testing” is not a realistic comparator and thus will not be evaluated.

244. Trends in the use of echocardiography, 2007 to 2011 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/echocardiography_research.pdf
     May 01, 2014 - 12 The criteria vary by previous service and clinical indication, but in gen- eral echocardiography testing … unclear - in the case of stress echo- cardiography, the relationship between the office location of testing … material and increased cost of care after testing is modest.13 However, evidence indicates that physicians … : an empiric analysis of cardiac stress testing with imaging. … Repeat testing among Medicare beneficiaries. Arch Intern Med 2012;172(22):1745-51. 19.

245. Renal-Function Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-function_research-protocol.pdf
     June 13, 2013 - Previous reviews and meta-analyses have investigated the prognostic performance of troponin testing … Note that for the population with suspected ACS (KQ 1-3), biomarker testing is done so routinely as … part of standard care that “no testing” is not a realistic comparator. … hs troponin I Troponin testing in CKD vs non-CKD Troponin testing vs. … • For the population with suspected ACS (KQ 1-3), biomarker testing is done so routinely as part

246. Methods Guide for Medical Test Reviews Chapter 9 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-performance_methods.pdf
     July 01, 2012 - screening performance of the test, it quantifies the impact of patient management strategies that include testing … PSA levels are not elevated in as many as 15 percent of individuals with prostate cancer, making PSA testing

247. Imaging Tests for the Staging of Colorectal Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/colorectal-cancer-staging/research-protocol
     May 21, 2013 - Staging Systems Once the diagnosis has been established, patients with colorectal cancer undergo testing … The differences in the testing protocols associated with different imaging modalities can affect their … and treatment (when reported in the included studies) Adverse effects and harms Harms of testing … Intermediate outcomes such as test performance and harms of testing can be measured immediately after … For questions about the impact of testing on patient-oriented clinical outcomes, comparative studies

248. Bayesian Approaches to Indirect Comparisons | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/indirect-comparisons/abstract
     September 22, 2011 - characteristics (e.g., mean squared error for estimation or prediction, or Type I error and power for hypothesis testing

249. Evaluating Practices and Developing Tools for Comparative Effectiveness Reviews of Diagnostic Test Accuracy: Methods for the Joint Meta-Analysis of Multiple Tests (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diagnostic-tests-accuracy_research.pdf
     January 01, 2013 - algorithms in the frequentist and Bayesian settings, using approximate and discrete likelihoods to model testing … 1 Background The value of diagnostic testing for patient management ultimately derives from its effect … Testing primarily affects outcomes by indirect means, influencing downstream patient management decisions … , including decisions for further testing, and administration or choice of treatment. … screening programs do not rely on isolated markers, but combine sequential biochemical and ultrasound testing

250. Development of the RTI Item Bank on Risk of Bias and Precision of Observational Studies | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/rti-item-bank-bias-precision/research
     September 16, 2011 - eliminated and refined through face validity, cognitive, content validity, and interrater reliability testing

251. Technical Brief Disposition of Comments Report for Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colon-cancer-gene-profiling_disposition-comments.pdf
     December 14, 2012 - I did wonder why at several times the idea of only testing T3 tumors without MSI was mentioned instead … of suggesting that testing be restricted to all Stage II tumors without MSI but since it was just a … Most of the studies were for prognostic testing, but predictive testing is the more important clinical … in or..” such that the first sentence would be changed to, “Because the topic of this Brief is GEP testing … Clarification of “patients for testing” will be very important as clinical algorithms for use of GEP

252. Project Name: (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_disposition-comments.pdf
     October 25, 2011 - Phase testing is basically a non-productive use of time and money. … Of the 53 patients randomized to testing by PM, 4 patients were without OSA. … Of the 53 patients randomized to testing by PSG, 6 were without OSA. … be missed because of night-to-night variation inherent in the PSG testing process. … results of initial tests) with full testing (overnight PSG) alone.

253. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypothyroidism-hyperthyroidism-screening-treatment_research-protocol.pdf
     March 11, 2010 - of serum free T4 and free T3 if the TSH falls outside of the normal range.1 Additional testing is … predicated on the results of this testing for diagnostic purposes and exclusion of other conditions. … Interventions • Screening interventions • : Serum TSH, with testing of serum free T4 and/or T3 if … , additional testing for thyroid antibodies, etc). … Analytic Framework Treatment/ testing

254. PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/prostate-cancer-antigen-3-gene/research

255. Appendix: Methods Guide for Medical Test Reviews: Test Performance Metrics | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/test-performance-metrics
     June 01, 2012 - Appendix: Methods Guide for Medical Test Reviews: Test Performance Metrics Timeline May 21, 2012 Topic Initiated June 01, 2012 Methods Guide – Chapter Appendix: Test Performance Metrics

256. Localized Prostate Cancer | Effective Health Care
     effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/08.html
     June 08, 2018 - by a biopsy and appears to be only located completely inside the prostate gland (based on available testing

257. S77 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s77.pdf
     October 01, 2007 - Because the VA has detailed records regarding both phar- macy utilization and means testing, it is possible … and Eligibility This study includes an analysis of all veterans age 65 and older who underwent means testing … 7079/07/4500-0077 Medical Care • Volume 45, Number 10 Suppl 2, October 2007 S77 Measures Key means testing … income, assets, and number of dependents are collected administratively during required annual means testing … RESULTS Of 11,907 veterans over the age of 65 who had means testing at the Salt Lake City VA in FY 2005

258. Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/chronic-kidney-disease-anemia-2011/research
     October 12, 2012 - suggest that CHr may reduce potential harms from IV iron treatment by lowering the frequency of iron testing … , although the evidence for the potential harms associated with testing or test-associated treatment

259. Chronic-urinary-retention-protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research-protocol.pdf
     November 19, 2012 - Testing and Treatment Treatment for CUR is dependent on etiology. … Therefore, providers may first conduct testing to identify the etiology. … The presence and severity of symptoms is a consideration in testing decisions. … UA) • urine culture • measures of renal function • prostate-specific antigen (PSA) • urodynamic testing … is commonly performed, there is no standard set of tests or consensus regarding whether testing improves

260. Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cancer-pancreas/research-protocol
     August 09, 2013 - factors (e.g., Peutz-Jeghers syndrome, Lynch syndrome, and BRCA2, PALB2, and p16 mutations) motivate testing … Testing for recurrent pancreatic cancer is excluded. … exp diagnostic errors/ or exp diagnostic error/) 34 Pancreatic cancer and imaging and diagnostic testing